See every side of every news story

Published 24 hours ago • loading... • Updated 19 hours ago

UCB advances its digital antibody engineering program with new Cradle collaboration

UCB and Cradle announced a strategic collaboration focused on digital antibody discovery and engineering.
The collaboration expands UCB’s digital antibody program by combining its antibody discovery platform with computational science, disease-biology expertise, and research partners.
UCB plans to use Cradle’s AI-driven protein design platform in selected projects from hit generation through lead optimization and preclinical readiness.

Insights by Ground AI

15 Articles

15 Articles

The Paintsville Herald

+12 Reposted by 12 other sources

UCB advances its digital antibody engineering program with new Cradle collaboration

Collaboration adds Cradle's end-to-end platform to UCB's computational capabilities, supporting faster discovery of complex therapies for severe diseases

24 hours ago

Read Full Article

UCB Taps AI Startup Cradle to Help Design Antibody Drugs

2 days ago·New York, United States

Read Full Article

UCB to Use AI for Medication Development

The Belgian pharmaceutical group UCB is partnering with the Swiss-Dutch start-up Cradle Bio for the development of new medicines.

19 hours ago·Belgium

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources15

Leaning Left3Leaning Right2Center7Last Updated41 minutes agoBias Distribution

58% Center

Bias Distribution

58% of the sources are Center

58% Center

+2

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Bloomberg broke the news in New York, United States 2 days ago on Tuesday, November 3, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics